[HTML][HTML] Coagulopathy and antiphospholipid antibodies in patients with Covid-19

…, J Wang, B Du, Y Qin, P Gao, X Qin, Y Xu… - … England Journal of …, 2020 - Mass Medical Soc
Coagulopathy in Critical Illness with Covid-19 The authors describe a 69-year-old man with
Covid-19 diagnosed in January 2020 in Wuhan, China, along with two other critically ill …

[HTML][HTML] IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19

…, L Su, D Zhang, J Fan, Y Yang, M Xiao, J Xie, Y Xu… - Molecular …, 2020 - Springer
Background COVID-19 is a viral respiratory disease caused by the severe acute respiratory
syndrome-Coronavirus type 2 (SARS-CoV-2). Patients with this disease may be more prone …

Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009–2010 results from the …

…, HJ Tang, KW Yu, YS Chen, YC Chuang, Y Xu… - International journal of …, 2012 - Elsevier
In 2009, the Study for Monitoring Antimicrobial Resistance Trends (SMART) was expanded
to include surveillance of Gram-negative pathogens causing urinary tract infections (UTIs) in …

Molecular Epidemiology of Clinical Isolates of Carbapenem-Resistant Acinetobacter spp. from Chinese Hospitals

…, H Sun, H Wang, Q Yang, M Chen, Y Xu… - Antimicrobial agents …, 2007 - Am Soc Microbiol
Carbapenem resistance in Acinetobacter spp. is an emerging problem in China. We investigated
the molecular epidemiology and carbapenemase genes of 221 nonrepetitive imipenem…

[HTML][HTML] Emerging new therapeutic antibody derivatives for cancer treatment

S Jin, Y Sun, X Liang, X Gu, J Ning, Y Xu… - … and Targeted Therapy, 2022 - nature.com
Monoclonal antibodies constitute a promising class of targeted anticancer agents that enhance
natural immune system functions to suppress cancer cell activity and eliminate cancer …

Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome

B Du, Y Long, H Liu, D Chen, D Liu, Y Xu, X Xie - Intensive care medicine, 2002 - Springer
Objectives. To study the risk factor for nosocomial bacteremia caused by Escherichia coli or
Klebsiella pneumoniae producing extended-spectrum beta-lactamase (ESBL) and the …

Antiphospholipid antibodies in critically ill patients with COVID‐19

…, P Gao, M Lu, X Hou, X Wu, H Zhu, Y Xu… - Arthritis & …, 2020 - Wiley Online Library
Objective Coagulopathy is one of the characteristics observed in critically ill patients with
coronavirus disease 2019 (COVID‐19). Antiphospholipid antibodies (aPLs) contribute to …

[HTML][HTML] Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients

…, S Tan, D Guo, X Zhao, Y Ye, W Wu, Y Xu… - Nature …, 2014 - nature.com
A novel influenza A (H7N9) virus of avian origin emerged in eastern China in the spring of
2013. This virus causes severe disease in humans, including acute and often lethal …

Profiling early humoral response to diagnose novel coronavirus disease (COVID-19)

…, Y Xu, QW Yang, SY Xu, HD Zhu, YC Xu… - Clinical infectious …, 2020 - academic.oup.com
Background The emergence of coronavirus disease 2019 (COVID-19) is a major healthcare
threat. The current method of detection involves a quantitative polymerase chain reaction (…

Cryptococcus neoformans, a global threat to human health

…, Z Liu, Y Sun, M Chen, G Liao, C Ding, Y Xu… - Infectious Diseases of …, 2023 - mednexus.org
Background Emerging fungal pathogens pose important threats to global public health. The
World Health Organization has responded to the rising threat of traditionally neglected …